The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
March 20th 2025
BeeR is a bacterial protein from the family Verrucomicrobiota that influences cell shape and division.
Lifileucel Approval Paves the Way for Personalized Minimally-Invasive T-Cell Therapies
February 25th 2025The FDA’s accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.
Read More
James P. Allison and the Discovery of CTLA-4: How Immune Checkpoint Blockade Revolutionized Oncology
February 25th 2025Immunotherapy pioneer James P. Allison, PhD, revolutionized cancer treatment by discovering immune checkpoint blockade, leading to significant advances in survival rates and ongoing efforts to optimize immuno-oncology strategies.
Read More
Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment
BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
Read More
Key Sessions and Opportunities for Pharmacists at the AACR Immunotherapy Conference
February 21st 2025The AACR Immunotherapy Conference 2025 will provide pharmacists with the opportunity to engage with cutting-edge cancer immunotherapy research, explore advancements in treatments, such as immune checkpoint inhibitors and CAR T-cell therapy, and connect with key leaders in the field.
Read More
New Therapy for Chronic Graft-Vs-Host Disease: Axatilimab
Axatilimab is a colony-stimulating factor-1 receptor–blocking monoclonal antibody indicated after 2 lines of systemic therapy.
Read More
C. Brooke Adams, PharmD, BCOP, discusses the evolving diagnostic criteria and management strategies for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR T-cell therapy, highlighting advances in toxicity prevention and treatment selection.
Read More